Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) Other Operating Expenses (2019 - 2025)

Volitionrx (VNRX) has disclosed Other Operating Expenses for 9 consecutive years, with $1.0 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Other Operating Expenses rose 3214.23% year-over-year to $1.0 million, compared with a TTM value of $2.0 million through Sep 2025, down 44.57%, and an annual FY2024 reading of -$34731.0, down 119.22% over the prior year.
  • Other Operating Expenses was $1.0 million for Q2 2025 at Volitionrx, up from $917299.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $1.9 million in Q4 2023 and bottomed at -$33498.0 in Q2 2024.
  • Average Other Operating Expenses over 5 years is $962118.6, with a median of $980251.5 recorded in 2025.
  • The sharpest move saw Other Operating Expenses tumbled 100.0% in 2024, then skyrocketed 3214.23% in 2025.
  • Year by year, Other Operating Expenses stood at $1.8 million in 2021, then dropped by 22.18% to $1.4 million in 2022, then soared by 34.34% to $1.9 million in 2023, then plummeted by 100.0% to -$38.0 in 2024, then soared by 2745373.68% to $1.0 million in 2025.
  • Business Quant data shows Other Operating Expenses for VNRX at $1.0 million in Q2 2025, $917299.0 in Q1 2025, and -$38.0 in Q4 2024.